QHSLab, Inc.

QHSLab Initiates Pivotal Clinical Trial (NCT06603935) for Digital Allergic Rhinitis Management Platform

QHSLab, Inc. has initiated a pivotal clinical trial (NCT06603935) for its digital medicine platform, integrating Allergy Management Evaluation (AME) and Allergic Rhinitis Intervention Steps (ARIS) to enhance allergic rhinitis control in primary care. This 12-month, randomized study targets 240 adults, evaluating symptom severity, adherence, and economic impact, signaling a strategic move in digital health for chronic condition management.